Welireg (Belzutifan)
- Medicine Name: Welireg
- Generic Name: Belzutifan
- Dosage Form & Strength: Tablets: 40 mg
- Manufactured By: Merck
Medical Uses
Welireg is a hypoxia-inducible factor inhibitor used to treat adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring prompt surgery.
Recommended Dosage: The recommended dosage is 120 mg administered orally (by mouth) once daily until the disease is progressive or unacceptable toxicity occurs. Welireg must be taken at the same time every day and may be taken with or without meal. Patients should swallow the Welireg tablets whole, without chewing, crushing, or splitting.
If a dose is missed/skipped, it can be taken as promptly as possible on the same day. Resume the regular daily dose schedule the very next day. Do not take additional tablets to make up for the missed/skipped dose.
In case vomiting occurs any time after taking the dosage, avoid retaking the dose. Patients should take the next scheduled dose on the very next day.
Warning & Precautions
- Welireg 40 mg tablets can cause severe anemia that can require blood transfusion. Monitor for anemia prior to initiation of, and periodically throughout, therapy with Welireg. Precisely assess those who are dual UGT2B17 & CYP2C19 poor metabolizers because of potential increases in exposure that may increase the incidence or severity of anemia.
- Consideration of erythropoiesis stimulating agents (ESAs) to treat anemia is not recommended in those treated with Belzutifan. For those treated with Belzutifan who develop anemia, the safety as well as effectiveness for use of erythropoiesis stimulating agents have not been established.
- Belzutifan can cause serious hypoxia that may require interruption, supplemental oxygen, or hospitalization. Monitor oxygen saturation prior to initiation of, and periodically throughout, therapy with Belzutifan. For decreased oxygen saturation with exercise (pulse oximeter <88% or PaO2 ≤55 mm Hg), consider withholding Belzutifan until pulse oximetry with exercise is beyond 88%, then resume at the same dose or at a decreased dose.
- For reduced oxygen saturation at rest (pulse oximeter <88% or PaO2 ≤55 mm Hg) or urgent intervention indicated, withhold treatment with Belzutifan 40 mg tablets until resolved and resume at a decreased dose or discontinue. For life-threatening hypoxia or for recurrent symptomatic hypoxia, permanently discontinue treatment. Patients must report signs/symptoms of hypoxia promptly to a health specialist.
- Welireg can cause fetal harm if administered to a pregnant woman. Verify the pregnancy status of females of reproductive age prior to starting therapy with Welireg. Females of reproductive age should use apt non-hormonal contraception during therapy with Welireg and for 7 days after the final dose. This medicine can render some hormonal contraceptives ineffective.
Documentation & Availability
What documents are required to import WELIREG to India?
WELIREG (belzutifan) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is WELIREG available in India?
WELIREG (belzutifan tablet) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
WELIREG can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of WELIREG (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Welireg price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the WELIREG (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Welireg®?
Belzutifan is Generic Name for the trade name drug Welireg®.
What is the Manufacturer Name of Welireg®?
Welireg® is manufactured by Merck.
Is Welireg® approved by the FDA?
Yes, Welireg® is approved by the FDA. Date of first/initial approval: August 13, 2021.
Where can I get Welireg® at the best price in India?
To get the best Welireg- Belzutifan price in India, kindly contact S S Healthcare (a WHO GDP & ISO 9001 : 2008 certified company). For Welireg®, a valid medical prescription is required from your treating physician.
What is the dosage and form of Welireg® supplied?
Welireg® is supplied as Tablets: 40 mg for oral administration.
What are the most common side effects with Welireg®?
The most common side effects with Welireg® include: anemia, fatigue, decreased hemoglobin, increased creatinine, headache, increased glucose, dizziness, and nausea.
How much does Welireg® cost in India?
The cost of welireg in India is less and can vary. In order to procure this medication authentically, you can Call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Welireg®?
Store at room temperature between 68°F to 77°F (20°C to 25°C). Bottle contains two desiccant canisters that help keep your medication dry. Never eat the desiccant canisters.
Is it safe to buy Welireg® online from India?
Yes, You can buy Welireg tablets online at the best price from the S S Healthcare if Welireg® has not been approved or is not available in your country.
What are the Highlights of prescribing information for Welireg®?
Click Here to download full Welireg prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
